Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171590 | SCV000055251 | uncertain significance | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Illumina Laboratory Services, |
RCV000346721 | SCV000470375 | uncertain significance | Congenital long QT syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000284774 | SCV000627716 | benign | Long QT syndrome | 2023-12-12 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000853028 | SCV000995785 | likely benign | Hypertrophic cardiomyopathy | 2017-11-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000171590 | SCV001905301 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002326938 | SCV002632939 | likely benign | Cardiovascular phenotype | 2020-08-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003230431 | SCV003928241 | likely benign | not specified | 2023-04-09 | criteria provided, single submitter | clinical testing | |
Dept of Medical Biology, |
RCV000284774 | SCV004022071 | uncertain significance | Long QT syndrome | 2024-01-08 | criteria provided, single submitter | research | Criteria: BS1 |